New group promotes cheaper medicines to tackle EU healthcare pressures
This article was originally published in SRA
Executive Summary
A group of German companies specialising in parallel trade, drug distribution, generics and homecare has formed an association to promote its members’ products and services to European policymakers concerned about the rising costs of healthcare1.
You may also be interested in...
First African Approvals For Merck’s Ebola Vaccine
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
EU Parliament Urges Post-Brexit Cooperation
Life science companies will be pleased to hear that the European Parliament is pressing for close cooperation between the UK and the EU in the area of medicines regulation.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: